Location: San Diego Convention Center
Cellistic at Bio International Convention 2026 in San Diego | iPSC Cell Therapy CDMO
Cellistic will attend the BIO International Convention 2026, bringing its integrated GMP manufacturing platforms and iPSC expertise to one of the industry’s most dynamic partnering events. As part of the Belgian pavilion, we will showcase how Cellistic is enabling the transition of iPSC-based therapies from scientific promise to clinically and commercially viable solutions.
Our team will be on site in full force, including our CEO, CTO, and Business Development team, ready to engage with partners across the biotech and pharma landscape.
Connect with our experts to explore how Cellistic, as an iPSC-focused CDMO, enables not only the development and scalable manufacturing of allogeneic cell therapies, but also addresses the financial and commercial viability challenges of iPSC-based therapies—from cost of goods to scalable platform design.
We will showcase our GMP manufacturing platforms, including:
- Echo™-Cardio for cardiomyocytes
- Echo™-Endothelial for endothelial cells
- Echo™-T for α/β T cells & Tregs
- Echo™-NK for natural killer (NK) cells
Built on 15+ years of iPSC expertise, our platforms accelerate your path to clinic with scalable, cost-effective iPSC-derived solutions.
We look forward to connecting with drug developers advancing cell therapy and regenerative medicine programs.
Meet our team
Meet our team at BIO International Convention in San Diego—Jason Conner (CEO), Stefan Braam (CTO), Tarran Pierfelice (CCO), Wesley Tidball (Senior Business Development Director), and Fionn Huang (Senior Business Development Director, APAC)—on site throughout the week to engage in strategic discussions and explore partnership opportunities.